Please use this identifier to cite or link to this item: http://repository.uinjkt.ac.id/dspace/handle/123456789/36948
Title: Chymase inhibition prevents myocardial fibrosis through the attenuation of NOX4‐associated oxidative stress in diabetic hamsters
Authors: Yasutaka Maeda; Toyoshi Inoguchi; Ryoko Takei; Hari Hendarto; Makoto Ide; Tomoaki Inoue; Kunihisa Kobayashi; Hidenori Urata; Akira Nishiyama; Ryoichi Takayanagi
Issue Date: 2012
Publisher: Asian Association for the Study of Diabetes and John Wiley & Sons Australia, Ltd
Abstract: Aims/Introduction:  Diabetic cardiomyopathy entails the cardiac injury induced by diabetes, independent of vascular disease or hypertension. Despite numerous experimental studies and clinical trials, the pathogenesis of diabetic cardiomyopathy remains elusive. Here, we report that chymase, an immediate angiotensin II (AngII)‐forming enzyme in humans and hamsters, and NOX4‐induced oxidative stress have pathogenic roles in myocardial fibrosis in diabetic hamsters. Materials and Methods:  Expression of chymase was evaluated in the hearts of streptozotocin (STZ)‐induced diabetic hamsters. The impact of chymase‐specific inhibitors, TEI‐E00548 and TEI‐F00806, on myocardial fibrosis, and increased levels of intracardiac AngII, accumulation of 8‐hydroxy‐2′‐deoxyguanosine (an oxidative stress marker in urine and heart tissue) and expression of heart NOX4 in diabetic hamsters were investigated. Results:  Myocardial chymase expression was markedly upregulated in STZ hamsters in a glucose‐dependent manner. A total of 8 weeks after STZ administration, the diabetic hamsters showed enhanced oxidative stress and NOX4 expression in the heart, in parallel with increased myocardial AngII production. Oral administration of chymase‐specific inhibitors, TEI‐F00806 and TEI‐E00548, normalized heart AngII levels, and completely reversed NOX4‐induced oxidative stress and myocardial fibrosis in STZ‐induced diabetic hamsters, although they did not affect the activity of the systemic renin–angiotensin system or systolic blood pressure. Conclusions:  Chymase inhibition might prevent oxidative stress and diabetic cardiomyopathy at an early stage by reducing local AngII production.
metadata.dc.description.uri: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4019255/
URI: http://repository.uinjkt.ac.id/dspace/handle/123456789/36948
ISSN: ISSN: 2040-1124
Appears in Collections:Post Print

Files in This Item:
File SizeFormat 
Chymase inhibition prevents myocardial fibrosis.png223.91 kBimage/pngView/Open


Items in UINJKT-IR are protected by copyright, with all rights reserved, unless otherwise indicated.